In its May 2026 evaluation, the FDA identified one small meeting abstract describing a short randomized study in people with ulcerative colitis
No routine CBC or hepatic panel required for typical cosmetic-dose topical use on intact skin
[78] Cellular respiration abnormalities in cellular respiration including a reduction in glycolysis, [79] including impaired pyruvate dehydrogenase [80] increased lactic acid [81] [82] [83] [84] [4] reduction in metabolites reflecting a slowed metabolism [85] analysis of peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction, supporting a model...that would suggest an elevation of oxidative stress
Integrating these research results, GPX4 can be regarded not only as a potential biomarker sensitively reflecting OA pathological severity and disease stage but also as a therapeutically promising target with core protective functions in OA progression
After 6 weeks at 250mcg twice daily, my symptoms are about 80% improved
Metabolic parameters including energy expenditure, RER, locomotor activity, and cumulative food intake were continuously recorded and analyzed
